Podcasts about glp1

Jay Campbell is a 5x international best-selling author, men's physique champion, and the Owner and Co-Founder of BioLongevity Labs. Jay is also the author of The Definitive Testosterone Replacement Therapy Manual: How to Optimize Your Testosterone for Lifelong Health and Happiness”.  Widely recognized as a leading expert on hormonal optimization, therapeutic peptides, and biohacking for health and performance, Jay is on a mission to help individuals break free from the failing "sick care" system and take control of their health.   https://biolongevitylabs.com/ - CODE "ScottM" to save https://www.instagram.com/jaycampbell333/ https://jaycampbell.com/   Use code "ScottM" at www.BiolongevityLabs.com to save on all Peptides including GLP-1s like Retatrutide aka GLP3, BPC157 and TB500, Tesamorelin/Ipamorelin, and much more! Get the best prices on quality, lab-tested peptides and help support the show. This podcast is brought to you by LMNT Electrolytes! It's great for a hot summer day, a workout, or just working at your desk with cold water. Check it out and get your free sample pack along with any regular purchase when you use my custom link, www.drinklmnt.com/ScottMys. The LMNT Sample Pack includes one packet of their most popular flavors. This is the perfect offer for 1) anyone who is interested in trying all of our flavors or 2) anyone who wants to introduce a friend to LMNT. Go to www.drinklmnt.com/ScottMys to claim this awesome deal!   Interested in working with me 1-1? I offer personalized coaching where I can help you reach your goals whether it be fat loss, muscle building, health improvements, or all of the above. I provide tailored nutrition, training, and supplementation advice (one or all together) with 24/7 ongoing support to help guide you every step of the way. DM me on Instagram and I can answer any questions. If you like, we can even set up a FREE consult call to go over your goals, answer questions, and discuss what it could look like to work together!

#askthedr #askthedoctor #askthedoctors8/30/25. Dr Michael Lange and Dr Susan Summerton host syndicated medical talk show called "ask the dr" today from Salem Media in Tampa Fl. Start off the show inviting everyone to the Annual October Fest Fall Festival held at the Lange Eye Institute every year. This hear will be studio 51/ Disco theme and will be held form 10-2 on October 4th. Lots of free food, drink, music with huge discounts on the Fortifeye Vitamin line and all optical products. Dr Lange and Dr Summerton also mentioned they are in a hiring phase currently and looking for lots of new employees. Todays show is: what nutrients are crucial for overall well-being and good ocular health. A segment on weight loss simple math and improve near vison with Astareal astaxanthin. Dr Lange discussed his weight loss from his one-month boot camp and gives some tips how to lose weight safely and quickly. One caller called Dr Lage her Saturday health coach and she has been listening to "ask the dr" for many years while in Florida and now listens in Chicago. Both doctors discuss the amazing dry eye procedure using the only FDA approved IPL for dry eye treatment called Lumenis Opti Light. Dr Lange briefly talks about Lumenis Opti Lift for improving lower lid laxity. Dr Summerton does a great section on the powers of magnesium and the different types of magnesium and their benefits. Both doctors discuss the new science behind vitamin c and healthy skin. Dr Lange promotes the all new Fortifeye Next Gen Vitamin c with time released vitamins c. They also discuss new studies proving omega 3 is good for the brain at levels between 1000-2400 mg daily. Both docs discuss how to reduce the side effects of weight loss GLP1 receptor drugs and gave some good examples. These drugs have potential negative side effects that can be minimized with specific nutrients and exercise. Learn more and order Fortifeye supplements at www.fortifeye.com or call 866 503-9746 #askthedr #askthedoctor #askthedoctors #drmichaellange #drsusansummerton #drlangewellness #veganprotein #dryeyerelief #proteinpowder #lumenis #lumenisoptilift #lumenisoptilight #weightlossjourney #weightmanagement #weightlossmotivation #weightlossdiet #weightlosstransformation #drlangebootcampSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

Dr. Alex Menze and Dr. Christopher J. Klein discuss whether GLP-1RA usage is linked to radiculoplexus neuropathy and common fibular neuropathy.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213916   

Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Jameela Jamil Calls Out Serena Williams for promoting a GLP1 medication. And Millie Bobbi Brown and Jake Bongiovi were spotted with their new baby girl!See omnystudio.com/listener for privacy information.

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Today is a Plus SideZ Rewind! Two years ago, we sat down with the one and only Rosie O'Donnell at the dawn of our movement for affordable access to GLP-1 medications & ending the stigma around treating obesity as a disease. Now, as we stand well into season five with thousands of new subscribers, so it's time for a little time-travel! We're bringing you a “Rewind” of that pivotal conversation to let our new listeners hear where it all began and let our longtime supporters see just how far we've come.In this flashback, we revisit that summer of 2023 when the Mounjaro $25 Savings Card Coupon was ending and people were flocking to compound GLP-1 which still had a lot of question marks surrounding it. And the shortage of all GLP-1s was growing. There was no Zepbound or cash pay price or branded vials. It was $1400-1000 a month go get access to branded GLP-1s. With more voices in the conversation today, we're measuring our progress from that. Oh how far we've come! We can now get branded GLP-1 for under $500. That's a ton of movement in a short time. But let's get it lower! Keep the faith. Let's get loud AND change things! ______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Commando Steve, former Biggest Loser coach, weighs in on the new Netflix documentary 'Fit for TV: The Reality of The Biggest Loser' and Serena Williams' GLP1 Product Endorsement.. Catch The Jimmy & Nath Show with Emma live on 1041 2Day Monday to Friday from 6am-9am! Follow us on Instagram and TikTok @thejimmyandnathshowwithemma Want your jokes to be on our pod? Send them in a voice note here: hello@jimmyandnath.com Subscribe on LiSTNR: https://play.listnr.com/podcast/the-jimmy-and-nath-show See omnystudio.com/listener for privacy information.See omnystudio.com/listener for privacy information.

Jessica Brennan, started in the fitness industry 10 years ago as a fitness instructor and personal trainer, realized early on that achieving health goals went beyond physical activity. This realization led Jessica to pursue certifications in nutrition, hormone specialist, and gut health specialist, aiming to address health challenges holistically. Working closely with Karen at Hormone Solutions, Jessica is dedicated to sharing her expertise with women globally. Her areas of expertise include bodybuilding, women's hormone health, personalized nutrition, peptide therapy, and chronic illness management. Jessica is with me this time to discuss our one-year anniversary of being on weight loss peptides. We also created our weight loss peptide group about a year ago which, in addition to our own experiences, has provided us many different points of view on the ups and downs that members face. We'll share personal stories and lessons learned from our community of over 200 members, discussing the use of GLP-1 peptides, strategies for minimizing side effects, and the importance of muscle preservation. We also get into how peptides can improve sleep, athletic performance, and hormonal balance. In this episode: How weight loss peptides and hormone optimization can transform wellness and fitness goals. Optimizing peptide regimens to minimize side effects and prevent muscle loss. Why holistic health approaches are crucial for long-term wellness beyond just weight reduction. Why addressing foundational health practices enhances the success of hormonal treatments. How hormone balance plays a crucial role in weight control and muscle preservation, especially during menopause. Why effort and the right mindset are non-negotiables for achieving fitness goals. How the CAROL Bike can aid in maximizing workout efficiency while using peptides. Why women should progress beyond comfort zones in weightlifting for muscle development. How peptides synergize with training, emphasizing workout efficiency for busy individuals. Why long-term peptide use may be necessary for ongoing health maintenance and weight management. How guilt associated with medication for weight control should be reframed as a preventive health measure. How GLP-1 agonists impact the immune system, mental health, and metabolic functions. Tirzepatide's positive influence on thyroid function. How addressing hormonal imbalances in conjunction with weight loss efforts leads to better outcomes. Why community support can be transformative in the health and fitness journey.   Sponsors Coupon KM20 to get 20% off your order of Vitali Skin Care! Get 40% off your Cozy Earth Bed Sheet with coupon code HORMONES     Are you in peri or post menopause and looking to optimize your hormones and health? At Hormone Solutions, we offer telemedicine services and can prescribe in every U.S. state, as well as in British Columbia, Alberta, and Ontario in Canada.   Visit karenmartel.com to explore our comprehensive programs: Bioidentical Hormone Replacement Therapy Individualized Weight Loss Programs  Peptide Therapy for weight loss    Interested in our NEW Peptide Weight Loss Program? Join today and get all the details here.   Join our Women's Peri and Post Menopause Group Coaching Program, OnTrack, TODAY!   To our nursing audience members, our podcasts qualify for nursing CE @ RNegade.pro. Provide # CEP17654.   Your host: Karen Martel Certified Hormone Specialist, Transformational Nutrition Coach, & Weight Loss Expert   Karen's Facebook Karen's Instagram

The FDA warns customers to not eat raw frozen shrimp at Walmart because it's been contaminated with radioactive chemicals. Scientists are working on a GLP1 medicine for your pets. Microdosing on mushrooms is the new trend and it's increasing calls to poison control.See omnystudio.com/listener for privacy information.

Why You Should Listen:  In this episode, you will learn about hair loss and some of the leading edge treatment options available today. About My Guest: My guest for this episode is Dr. Alan J. Bauman.  Alan J. Bauman, MD is an acclaimed board-certified hair restoration physician with nearly 30 years of experience in the medical field.  He is the founder and CEO of Bauman Medical, an international leading treatment center in the field of hair restoration.  Dr. Bauman received his Medical Doctor degree from New York Medical College in Valhalla, NY and underwent internship and residency training in surgery at Beth Israel Medical Center and Mt. Sinai Medical Center in Manhattan before dedicating his expertise to the specialized fields of hair transplant surgery and the treatment of hair loss.  With a particular focus on androgenetic alopecia or hereditary male or female pattern hair loss, Dr. Bauman has established himself as an authority in the industry.  He has treated over 34,000 patients, performed over 12,000 hair transplant surgeries, and administered over 12,000 PRP hair regrowth treatments.  He is a frequently invited faculty member and guest expert at numerous international scientific meetings and live surgery workshops and has been featured in hundreds of news stories in the media.  Dr. Bauman is one of approximately only 200 physicians worldwide to achieve the certification from the esteemed American Board of Hair Restoration Surgery (ABHRS).  He was voted “#1 Top Hair Restoration Surgeon” in North America by Aesthetic Everything for the 7th consecutive year, “Top Hair Restoration Surgeon of the Decade”, and received the 2022 “Lifetime Achievement Award in Hair Restoration”.  He was also recognized by Forbes as one of “10 CEOs Transforming Healthcare in America” and included in the ApeToGentlemen's list of the World's Best Hair Transplant Doctors for 4 years straight. Key Takeaways: What are the stages of hair loss? What are the different types of hair loss? What are some of the underlying causes of hair loss? What role do hormones play in hair loss? Can GLP-1s cause hair loss? Is hair loss genetic or epigenetic? What is the connection to thyroid function, Hashimoto's, and broader autoimmunity? What is the role of nutrient deficiencies in hair loss? What role do chronic Lyme, mold, or COVID play in hair loss? Do chronic scalp infections impact hair growth? Do certain medications cause hair loss? How important is supporting circulation to optimize hair growth? Do mitochondria play a role in hair growth? Are environmental toxicants a factor in hair loss? Does stress play a role in hair loss? What systemic or topical medications can be used to reduce hair loss and optimize hair growth? Do peptides have a place in supporting hair growth? What shampoos may be helpful for supporting hair growth? What is the role of PRP, stem cells, and exosomes in supporting hair growth? Does red light have a place in supporting hair growth? When might a transplant be the only option?  What supplements may support hair growth? Connect With My Guest:  BaumanMedical.com Related Resources: Bauman TURBO LaserCap Dr. Bauman offers a complimentary New Patient Evaluation ($500 value) with the purchase of a TURBO LaserCap. Interview Date: August 8, 2025 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode221. Additional Information: To learn more, visit https://BetterHealthGuy.com. Follow Me on Social Media: Facebook - https://facebook.com/betterhealthguy Instagram - https://instagram.com/betterhealthguy X - https://twitter.com/betterhealthguy TikTok - https://tiktok.com/@betterhealthguy Disclosure: BetterHealthGuy.com is an affiliate of Bauman Medical.  Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

Candice Bolden, entrepreneur and former professional dancer, opens up about her journey with PCOS (Polycystic Ovarian Syndrome) - from battling weight gain and skin issues to being told she'd struggle to conceive. With lots of research, faith, and support from her husband, ex-NFL player Omar Bolden, Candice reversed her symptoms through major lifestyle changes - and now they're proud parents to a baby girl! This episode is a powerful reminder that you can take control of your health and how motherhood can inspire a whole new mindset.Check out The Mama's Den episode with Candice's husband, Omar here: https://podcasts.apple.com/us/podcast/the-mamas-den/id1616159115?i=1000674715097________________________ We love getting Listener Letters! Send any thoughts or questions for the Mamas at podcasts@blacklove.com.Make sure you connect with our Mamas on IG: @themamasdenpodcastAshley - @watermeloneggrollsCodie - @codieco Melanie - @melaniefionaFor more Black Love interviews and articles, and to watch The Mama's Den podcast, visit www.BlackLove.com

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Join us as we chat with Dr. Spencer Nadolsky, founder of Sequence (now part of Weight Watchers), about the real-world journey of living with GLP-1 medications like Wegovy and Ozempic. We dive into the stages of this journey—why weight regain can happen, how to navigate plateaus, and how to rethink exercise and food tracking without the guilt. Dr. Spencer breaks down why obesity is truly a chronic condition and offers down-to-earth advice on managing each phase. It's all about understanding the path, avoiding common pitfalls, and feeling empowered on your GLP-1 journey_______________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Dr. Natalie Gentile calls in to talk about GLP-1s, the good and the bad she's seeing with patients.

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Doctor Warick Bishop, a cardiologist, author, and keynote speaker, discusses heart failure with preserved ejection fraction (HF PEF) in this podcast episode featuring Dr. Fiona Foo, a cardiologist in the Sydney Cardiology Group. They delve into HF PEF diagnosis, treatment, and prevention strategies, focusing on managing blood pressure, weight, and other risk factors like diabetes and kidney disease. They elaborate on medications such as SGLT2 inhibitors and GLP1 receptor agonists, which have shown benefits in reducing HF PEF hospitalizations and cardiovascular risks. By emphasizing lifestyle changes and pharmaceutical support, their conversation underscores the importance of maintaining a healthy weight and managing related conditions to reduce the risk of heart failure. It's a comprehensive discussion aimed at empowering listeners to prioritize heart health and make informed choices.

Michelle Hall is a recovering food addict, Primal Health Coach and fitness coach, and certified to help people using GLP1's. She helps women over 35 achieve food freedom. Find her on Instagram @coach_michellehall or at www.coachmichellehall.com.

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ___________________________________________________________________In this inspiring episode, we sit down with Jamie Selzler, a dedicated community member who has achieved a remarkable transformation, losing an incredible 340 pounds. Jamie shares his deeply personal journey, detailing his life in a larger body and how he successfully combined weight training with GLP-1 therapy to reach his goals. His story offers hope and practical insights for anyone navigating their own weight loss path.We also welcomed Dr. Koons, a board-certified obesity physician, who provides expert guidance on common challenges in weight loss. Dr. Koons tackles crucial topics like regain, plateaus (stalls), and metabolic function. He offers a compassionate and informed perspective on how individuals who have been impacted by diet culture can begin to heal their relationship with food and learn to effectively track their daily nutrition without guilt or shame.___________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez_____________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Why does menopause feel like a battle with your own body? If you've noticed sudden cravings, stubborn belly fat, or energy crashes, it's not just you—it's your hormones. We're breaking down the science behind menopause-related weight gain. From estrogen's role in hunger control to the metabolic slowdown no one warns you about, we'll uncover why midlife changes feel so unfair—and what you can do about it. Plus, stay tuned for a game-changing natural supplement that could help you take back control. Don't miss this empowering conversation!Special Guest: Sarah Kennedy, CEO of Calocurb, natural GLP1 activator

What is in the This Week in Science Podcast? This Week: Funding State, mRNA HIV vaccine, Radioactive rhino horn, Wasting Source, Editing Diabetes, Roaches, Cockatoos, GLP1, Snails, Roach Bots, Political Sway, and Much More to Prompt You to Think Scientifically! Become a Patron! Check out the full unedited episode of our podcast on YouTube or […] The post 6 August, 2025 – Episode 1025 – Prompting You to Think Scientifically appeared first on This Week in Science - The Kickass Science Podcast.

Wegovy, (often referred to as Ozempic) was approved by the FDA in June 2021. Now that we have lived 4 years of a GLP frenzied hellscape, there must be new data on how well GLP1's work and how many lives they have saved. The numbers must be pretty impressive right? Hint: It's not impressive…not at all. Join me for part one of this deep dive into these (not so) new weight loss drugs where I share exactly how much weight people lose, if it improves their health (or worsens it), and all sorts of other nonsense that has been happening in the ensuing years after the press heralded Wegovy as a “game changer” that will “end” fatness. TW: for mentions of weight, mentions of children taking the drug and other general anti-fat ideas. Episode show notes: http://www.fiercefatty.com/199 Support me on Ko-Fi and get the Size Diversity Resource Guide: https://kofi.com/fiercefatty/tiers Ragen's 3 bullet points on GLPs: https://www.instagram.com/p/DKa5xdovYxa/?igsh=bHh1Nml0NW82bG83 https://www.cnn.com/2024/05/02/health/wegovy-weight-loss-drug-new-prescriptions Changes smell: https://www.instagram.com/p/DL0fFPER4QX/?img_index=7&igsh=Mmttb3Y4cG10dHUx The Community Ozempic Stole: As Influencers Lose Weight, Their Followers Feel "Abandoned": https://www.teenvogue.com/story/community-ozempic-stole-influencers-lose-weight Ozempic's Origin Story is Insane: https://youtu.be/9dMpY-ZALXc?si=lb6r-d08fEo9XVKB Dr Rachel Millner: Some thoughts about GLP-1s for intentional weight loss versus fat liberation as a value: https://www.instagram.com/p/DLzrBuuRqfW/?img_index=6&igsh=ODZpMmwyemlhdmxt Another post from Rachel she describes the side effects of GLPs when taken at a higher dose for weight loss and anorexia side effects/complications: https://www.instagram.com/p/DLOUiFKI8TB/ Retatrutide study: https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Ragen's blog: https://weightandhealthcare.substack.com/p/weight-loss-drug-cage-match-part The Race Is On to Stop Ozempic Muscle Loss: Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs. Non paywall link: https://archive.ph/l25L9 https://www.nytimes.com/2024/02/08/well/live/ozempic-muscle-loss-exercise.html?utm_source=pocket_mylist The Race Is On to Stop Ozempic Muscle Loss: Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs. Non paywall link: https://archive.ph/l25L9 https://www.nytimes.com/2024/02/08/well/live/ozempic-muscle-loss-exercise.html?utm_source=pocket_mylist Changes smell: https://www.instagram.com/p/DL0fFPER4QX/?img_index=7&igsh=Mmttb3Y4cG10dHUx Hannah from Queenbeastsays, The Labour Government wants Britain to be "fat-free" by 2035: https://queenbeastsays.substack.com/p/the-labour-government-wants-britain?utm_source=app-post-stats-page&r=2qfqs8&utm_medium=ios&triedRedirect=true Contraception warning over weight-loss drugs after dozens of pregnancies: UK watchdog has had 40 reports relating to pregnancies in people using drugs such as Ozempic and Mounjaro https://www.theguardian.com/society/2025/jun/05/contraception-warning-over-weight-loss-drugs-after-dozens-of-pregnancies NPP Weight Loss Medications and Safety Planning: https://www.patreon.com/c/nalgonapositivitypride/home 7,000 potential claims already under active investigation Lawsuit Legal News+2Doyle APC Law Firm+2Darrow AI+2.

Dr. Robert Baron outlines major updates in type 2 diabetes care, emphasizing that blood sugar control alone does not significantly reduce cardiovascular risk, though it helps prevent microvascular complications. New guidelines now prioritize medications with proven cardiovascular and kidney benefits—GLP-1 receptor agonists and SGLT2 inhibitors—over traditional first-line therapy like metformin. Baron explains how these newer drugs not only lower blood sugar but also reduce the risk of heart attack, stroke, kidney disease, and heart failure, with added benefits such as weight loss. He also covers changes in screening, diagnosis, blood pressure goals, and individualized treatment strategies based on age, comorbidities, and patient preferences. [Health and Medicine] [Show ID: 40756]

Dr. Robert Baron outlines major updates in type 2 diabetes care, emphasizing that blood sugar control alone does not significantly reduce cardiovascular risk, though it helps prevent microvascular complications. New guidelines now prioritize medications with proven cardiovascular and kidney benefits—GLP-1 receptor agonists and SGLT2 inhibitors—over traditional first-line therapy like metformin. Baron explains how these newer drugs not only lower blood sugar but also reduce the risk of heart attack, stroke, kidney disease, and heart failure, with added benefits such as weight loss. He also covers changes in screening, diagnosis, blood pressure goals, and individualized treatment strategies based on age, comorbidities, and patient preferences. [Health and Medicine] [Show ID: 40756]

Dr. Robert Baron outlines major updates in type 2 diabetes care, emphasizing that blood sugar control alone does not significantly reduce cardiovascular risk, though it helps prevent microvascular complications. New guidelines now prioritize medications with proven cardiovascular and kidney benefits—GLP-1 receptor agonists and SGLT2 inhibitors—over traditional first-line therapy like metformin. Baron explains how these newer drugs not only lower blood sugar but also reduce the risk of heart attack, stroke, kidney disease, and heart failure, with added benefits such as weight loss. He also covers changes in screening, diagnosis, blood pressure goals, and individualized treatment strategies based on age, comorbidities, and patient preferences. [Health and Medicine] [Show ID: 40756]

My portfolio was way up yesterday - it's happened during 2 kinds of periods in the market. And we've got another day of HUGE earnings. Plus some other opportunities. Here are the links to all the sales: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SAVE ON TRENDSPIDER - GET THE ANNUAL SUBSCRIPTION TO GET MY 4 HOUR ALGORITHM ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare brain tumor.

Send us a textSo you've lost weight on a GLP-1 medication like Ozempic or Wegovy… but now you're thinking about stopping. What happens next?In this episode, we explore how to maintain your results after coming off GLP-1s. Studies show many people regain weight—but with the right strategies, you can keep the progress going.In this 15-minute episode, you'll learn how to:Rebuild hunger and fullness cues through mindful eatingProtect your metabolism with strength trainingStabilize blood sugar to reduce cravings and prevent fat regainThese aren't quick fixes—they're sustainable habits that will help you transition off medication with confidence and control.Your meds helped you start—now let your habits carry you forward.Listen in, choose one habit to focus on this week, and take your next step toward long-term success.Join us in our private Facebook group. Stop Chasing Wellness: Inner Circle Stop Chasing Wellness is an online wellness coaching company founded by two Holistic Health Coaches, Gina and Kristin. Be sure to check out all of our offerings including our book, Stop Chasing Wellness; Create It, and our growing catalog of Hormone Specific coaching courses. All of our courses and offerings are designed to help you feel and live your best life in a simplified way that works for you. You can find Stop Chasing Wellness on Facebook and Instagram

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ___________________________________________________________________In this inspiring episode, we sit down with Jamie Selzer, a dedicated community member who has achieved a remarkable transformation, losing an incredible 340 pounds. Jamie shares his deeply personal journey, detailing his life in a larger body and how he successfully combined weight training with GLP-1 therapy to reach his goals. His story offers hope and practical insights for anyone navigating their own weight loss path.We also welcomed Dr. Koons, a board-certified obesity physician, who provides expert guidance on common challenges in weight loss. Dr. Koons tackles crucial topics like regain, plateaus (stalls), and metabolic function. He offers a compassionate and informed perspective on how individuals who have been impacted by diet culture can begin to heal their relationship with food and learn to effectively track their daily nutrition without guilt or shame.___________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez_____________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Check out Marek Health at https://marekhealth.com/syatt and get 10% OFF your first order using code: SYATTIn this episode of The Jordan Syatt Mini-Podcast, I shoot the breeze and answer questions from listeners with my podcast producer, Tony, and we discuss:- Keeping the weight off after GLP1's- How to exercise when traveling for work- Incredible home gym equipment- The best exercises for improving posture- TRX only programs- How to stick to a program- Mixing Peloton with strength training- Rock climbing, Barre, Judo and Parkour- Flamin' Hots vs Takis and my favorite kinds of chips- And more...If you haven't heard this episode, you MUST listen to this episode about blood pressure: https://podcasts.apple.com/ca/podcast/how-to-improve-your-blood-pressure-my-story/id1348856817?i=1000558151464Use this discount code for Monkey Feet: https://bit.ly/4fDLXtRListen to my podcast with Dr. Spencer Nadolsky: https://podcasts.apple.com/us/podcast/famous-obesity-doctor-debunks-glp-1-weight-loss-shots/id1348856817?i=1000717566909Do you have any questions you want us to discuss on the podcast? Give Tony a follow and shoot him a DM on Instagram - @tone_reverie - https://www.instagram.com/tone_reverie/ I hope you enjoy this episode and, if you do, please leave a review on iTunes (huge thank you to everyone who has written one so far).Finally, if you've been thinking about joining The Inner Circle but haven't yet... we have hundreds of home and bodyweight workouts for you and you can get them all: https://www.sfinnercircle.com/

Happy Satiated Saturday! Something I've noticed in any body image healing exploration is how private body image concerns are. About 84% of women struggle with body image, yet something so prevalent is often kept hidden. I wonder what could change if how hard it is to live in a body could be openly discussed and supported, where conversations could look like: Person 1: How are you today?Person 2: I'm actually having a really hard time with my body image today.Person 1: Thanks for letting me know. I struggle a lot too. Is there anything you need in this experience today? I want to normalize body image struggles because I sense this might be the first step toward changing the conversations around living in a body. Rather than beginning with body acceptance or body love, sometimes you first just need to be with that, sometimes, because of a million different reasons, it is hard to be in your body and to like the way your body looks. In this week's Satiated Podcast episode, I chat with Anna Sweeney, Nutrition Therapist and Registered Dietitian, about: The complexities of body image healingThe impact of societal messaging and social mediaChallenging body image normsThe GLP-1 craze we're in right nowMedical stigmaFinding safety in the bodyYou can also read the transcript to this week's episode ​here​: https://www.stephaniemara.com/blog/navigating-the-complexities-of-body-imageI hope you can join me Wednesday, August 27th at 5:00 pm ET for my upcoming Befriending Your Body Image Challenges with Somatic Eating® Practices Workshop. You can learn more and sign up ​HERE​: https://satiated.mykajabi.com/offers/EkFBjX2Q/checkoutWith Compassion and Empathy, Stephanie Mara FoxKeep in touch with Anna: Website: www.wholeliferds.comInstagram: https://www.instagram.com/dietitiananna/Support the showKeep in touch with Stephanie Mara:Instagram: https://www.instagram.com/_stephaniemara/Facebook: https://www.facebook.com/stephaniemarafoxWebsite: https://www.stephaniemara.com/https://www.somaticeating.com/Linkedin: https://www.linkedin.com/in/stephmara/TikTok: https://www.tiktok.com/@stephaniemarafoxContact: support@stephaniemara.comSupport the show:Become a supporter: https://www.buzzsprout.com/809987/supportMy favorite water filter: https://www.pureeffectfilters.com/#a_aid=somaticeatingReceive 15% off my fave protein powder with code STEPHANIEMARA at checkout here: https://www.equipfoods.com/STEPHANIEMARAUse my Amazon Affiliate link when shopping on Amazon: https://amzn.to/448IyPl Special thanks to Bendsound for the music in this episode. ...

Literature Review 1) An exciting phase three trial with the CETP inhibitor Obicetrapib has shown serious promise for ASCVD and Alzheimer's Disease (AD). "In BROADWAY, a pre-specified AD sub-study was designed to assess plasma AD biomarkers in patients enrolled in the BROADWAY trial and evaluated the effects of longer duration of therapy (12 months) with a prespecified population of ApoE3/4 or 4/4 carriers. The sub-study included 1727 patients, including 367 ApoE4 carriers. The primary outcome measure was p-tau217 absolute and percent change over 12 months. Additional outcome measures included neurofilament light chain (“NFL”), glial fibrillary acidic protein (“GFAP”), p-tau181, and Aβ42/40 ratio absolute and percent change over 12 months. NewAmsterdam observed statistically significant lower absolute changes in p-tau217 compared to placebo over 12 months in both the full ITT population (p

#askthedoctor #podcast #wheyprotein Dr Michael Lange and Dr Susan Summerton host the longest running live medical talk show called "Ask the Dr" today August 2, 2025, form Salem Media. They discuss how to enhance the benefits of GLP1 weight loss drugs from a specific protein. Learn about the purest and most bio available protein that will help to stop sarcopenia that can be associated with GLP1receptor drugs. Sarcopenia is muscle wasting and strength loss. Fortifeye has developed 4 products that can be used in combination with GLP1 drugs to help stop the unwanted muscle loss. Fortifeye Super Protein, Fortifeye Grass Fed Whey Isolate, Fortifeye Super Vegan Protein and Fortifeye Fit Pro. Learn about these at www.fortifeye.com Most Americans are not consuming enough protein and both doctors go into more details on this subject. Dr Lange stated he started his Dr Langes Boot Camp for one month to lose 25 lbs. He started yesterday. Both docotrs discus Marine collagen tripeptides and Dr Lange mentioned Morikol and Fortifeye Rejuvenate Marine Collagen tripeptide. The doctors discussed how you must be careful when purchasing vitamins and learn to read labels making sure the supplements are not filled with toxic ingredients and very low levels of nutrients. Fortifeye Vitamin company is based on their motto Right Ingredients, Right Science, Right for You. A discussion on how to protect the retina and macula after cataract surgery with specific nutritional supplements. Dr Lange recommends everyone taking Fortifeye Focus after cataract surgery to increase macula pigment density and thus protect the macula against possible blue light damage. Both doctors see patients at the Lange Eye Institute in The Villages Fla. call 352 753-4014 for an appointment. Fortifeye Vitamins number is 866 503-9746 #askthedoctor #podcast #wheyprotein #dryeyerelief #wheyproteinisolate #askthedr #drmichaellange #motivation #wellnesssaturday #drlangewellness #antiagingtips #antiagingsecrets #grassfedwhey #grassfedprotein #newzealandwhey #proteinpowder #veganprotein #marinecollagen #marinecollagentripeptide #longevity #longevityshow #longestrunningmedicaltalkshow #optometry #optometrylife #optometristSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure.   When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app.   If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death.   Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said.   Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin.   https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom.  CEO Kevin Sayer will step down  & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain  executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score.   However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes.   “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.”     https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/   XX Formal recognition for the specialty of Diabetology.   Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone.       The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology   XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen.     About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday.   Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners         https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html   XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment.   What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism.   While the study didn't identify which artificial sweeteners were at play,   Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture.   Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk.   https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders.   The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs.   Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan.       That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge.   The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings.   That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/   XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html  

Send us a textDr. Meghan Garcia-Webb has been helping CEOs, attorneys, physicians, and consultants look and feel better for years, and she is attuned to the concerns of high achieving individuals, as well as the specific mindset traps that befall even the most organized personality.She is board-certified in Internal Medicine, Lifestyle Medicine, and Obesity Medicine, bringing her patients the latest evidence-based therapies. She is also certified as a life coach through The Life Coach School, the premier choice for physician coaches. Through this unique combination of skills, she has pioneered an innovative hybrid model of customized care, creating lasting results for patients with ease.Dr. Garcia-Webb earned her B.S. at Tufts University, and her M.D. from the University of Vermont Medical School. She completed her residency in internal medicine at the University of Massachusetts. In addition to her clinical work, she produces a weekly YouTube series, Weight Medicine with Dr. Meghan.Dr. Garcia-Webb has been featured in publications such as Time, GQ, Food & Wine, The NY Post, Men's Health, Newsweek, Prevention, and Parade magazine.Find Dr. Meghan Garcia-Webb at-YT- @Weight Medicine with Dr. Meghan MDhttps://weightmedicinemd.com/Find Boundless Body at- myboundlessbody.com Book a session with us here!

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Continuing our vital conversation from GLP-1s & Men's Health: Jhon Henri's Weight Loss Story P1, we welcome Dr. Catherine Toomer an expert on weight management, who offers her insights on weight, health, and metabolic well-being. Building on Jhon Henri's powerful story and how GLP1s changed his life, Dr. Toomer unpacks the complexities of obesity as a disease, the limitations of BMI, and why the focus should shift from simple weight loss to metabolic correction.Discover why societal views on weight, particularly for men, contribute to healthcare disparities, and how GLP-1 medications work beyond "food noise" to address underlying metabolic issues. Dr. Toomer also sheds light on the often-misunderstood connection between rapid weight loss and gallstones, and candidly discusses the physiological changes women experience during perimenopause and menopause, including the role of estrogen decline in weight gain.This episode is a must-listen for anyone seeking a deeper understanding of chronic weight management, the importance of advocating for your health, and the journey toward holistic well-being.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez____________________________Send us Fan Mail!Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Depuis quelques années sont apparus sur le marché les analogues du GLP1, des injections qui court-circuitent le cerveau et réduisent les envies de nourriture en augmentant le sentiment de satiété. Une révolution dans la prise en charge de l'obésité qui peut induire une perte de poids égale ou supérieure à la chirurgie bariatrique. Les médecins spécialisés dans l'obésité croulent sous les demandes et mettent en place des séances d'information afin de prévenir : ces médicaments ne sont pas une baguette magique et ne doivent pas être prescrits sans prise en charge multidisciplinaire. Reportages Géraldine Genetti Réalisation Jean-Daniel Mottet Production Laurence Difélix

The VENTOUX study of endurance athletes, the 10,000 step myth was not busted, rate vs rhythm control for AF, and GLP1 drugs and observational studies are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Endurance Athletes and Arrhythmia (again) VENTOUX trial https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.125.018470 II Daily Step Count and Health — no myths were busted. Lancet Public Health: https://doi.org/10.1016/S2468-2667(25)00164-1 III Rate vs Rhythm Control of AF Medscape: Everyone Deserves a Shot at the American Dream: Sinus Rhythm https://www.medscape.com/viewarticle/everyone-deserves-shot-american-dream-sinus-rhythm-2025a1000jle This Week in Cardiology, July 11, 2025 https://www.medscape.com/viewarticle/1002704 AFFIRM trial https://www.nejm.org/doi/full/10.1056/NEJMoa021328 AFFIRM substudy https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/486560 IV GLP-1 Drugs and Observational Studies Neurodegeneration and Stroke After Semaglutide and Tirzepatide https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836412 SUSTAIN-6 https://www.nejm.org/doi/full/10.1056/NEJMoa1607141 SELECT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Best known for weight loss and blood sugar control, GLP-1 drugs might also reduce the stubborn inflammation behind hidradenitis suppurativa (HS). Early research shows they may impact key inflammatory pathways—and even improve HS symptoms (including painful skin boils) without major weight loss.But big questions remain: How do they interact with current HS treatments? Who can prescribe them? What happens if you stop?Dermatologist and HS expert Dr. Steven Daveluy returns to unpack the science, share insights, and explore what this could mean for the future of HS care. Don't miss it!⭐️Mentioned in This Episode:- See all the references

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________In this candid and powerful episode of The Plus SideZ Podcast, we sit down with Jhon Henry, a GLP-1 advocate who shares his weight loss journey, the impact of food noise, and what it means to be a man navigating obesity, diabetes risk, and healthcare bias.Jhon opens up about growing up in a bigger body, feeling dismissed by doctors, discovering GLP-1 medications, and finding purpose in helping other men—especially Black men—advocate for their health. From overcoming stigma to building a care team that listens, his story is one of vulnerability, grit, and community.We also dive into why BMI is broken, the mental toll of lifelong weight loss pressure, and how GLP-1 medications are transforming lives beyond the scale. Plus, Kim and Kat talk about shifting the conversation toward hormone health, advocacy, and what comes after weight loss.Whether you're on a GLP-1, love someone who is, or just want to hear real talk about health and healing—this episode is for you.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Top Two: LIliana. North Star Deli, Bootlegger & Loring Park Art Festival and GLP1 drugs are changing how restaurants market, interesting update from Stephanie H. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

TSA has quietly changed the checking the shoes policy and is thinking about changing the liquid rule. Researchers believe that GLP1 medications could help prevent dementia. President Trump claims that he has convinced Coca Cola to use cane sugar in their beverages. A Michigan woman is suing Monster Energy because she claims she found a mouse in her energy drink. The doll handler for Annabelle the haunted doll is dead and the doll is currently missing.See omnystudio.com/listener for privacy information.

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________We're bringing back one of our most powerful and downloaded episodes from Season 1 — "Fat and Lazy" with Dr. Rosen — because we've got so many new subscribers who need to hear this.In this episode, Kim opens up about her own obesity story — the stigma, the shame, the survival with GLP-1. Dr. Rosen, a leading expert in weight loss surgery, breaks down how GLP-1 medications were reverse-engineered from bariatric surgery research and what that means for treatment today.Together, we dismantle the toxic myth of “fat and lazy” and make it crystal clear: obesity is not a character flaw — it's a chronic disease.If you're new to the pod or just need a reminder that you're not alone and it's not your fault, this one's for you.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Microdosing GLP1s has become a buzzword across social media, but most of what's being promoted isn't accurate or aligned with what I've taught. In this episode, I'm setting the record straight. From telemedicine companies marketing standard starting doses as “microdosing,” to influencers pushing products under the guise of inflammation support, it's time we talk about what's really going on. I'll break down the origins of this conversation, what the concept of microdosing was actually intended for, and why it's NOT an effective weight loss strategy. If you've seen my name mentioned in this space, or if you're confused by the mixed messaging online, this episode is for you. Topics Discussed: → What's the difference between microdosing and standard GLP1s? → Microdosing GLP1s vs standard dosing: how do they compare? → How is microdosing GLP1s different from regular dosing? → Microdosing or standard GLP1s – which one are you actually doing? → Are you really microdosing GLP1s, or just using the standard dose? Sponsored By: → BIOptimizers| Go to bioptimizers.com/tyna and use promo code DRTYNA to order Masszymes now and get 10% off any order → LVLUP | Head over to LVLUPHealth.com and use code DRTYNA at checkout to get 20% off your order sitewide.  → Manukora | Head to manukora.com/DRTYNA to save up to 31% & $25 worth of free gifts in Starter Kit, which comes with an MGO 850+ Manuka Honey jar. →Timeline | Head to timeline.com/DRTYNA and get 20% off with code DRTYNA  → Resilience | Go to https://store.drtyna.com/products/resilience and use code Resilience10 for 10% off the entire store    On This Episode We Cover:  → 00:00:00 - Introduction → 00:07:29 - The microdose strategy → 00:11:03 - Off-label use & chronic illness risks → 00:14:48 - Weight loss → 00:16:47 - Key benefits of GLP1s → 00:23:17 - NYT Interview  → 00:24:25 - Price splitting & influencer scams → 00:26:30 - GLP1 clickbait → 00:29:51 - Inflammation & aging → 00:36:31 - GLP1 Done Right University → 00:38:31 - Why microdosing is NOT effective → 00:40:13 - Titration → 00:44:09 - GLP1 treatment explained → 00:47:49 - Understanding different peptide types → 00:53:39 - Overview  Show Links: → GLP-1s Done Right University → Strength Corner → Metabolic Revamp Toolkit  Ozempic Uncovered Podcast Series: → EP 106: Ozempic Done Right Part 1 | Solo Episode → EP 107: Ozempic Done Right Part 2 | Solo Episode → EP. 109: Ozempic Done Right Part 3 | Solo Episode → Ep. 116: Berberine: NOT Nature's Ozempic | Quick & Dirty → EP. 118: My GLP-1 Experience | Quick & Dirty → EP. 129: Ozempic Done Right Part 4: Sustained Weight Loss | Solo Episode → EP. 132: Ozempic Done Right Part 5: Osteoarthritis + GLP1 Agonists | Solo Episode → EP. 136: Ozempic Does NOT Cause Muscle Loss | Solo Episode Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

Elizabeth welcomes Dr. Tyna Moore for a straight-shooting conversation on one of the most talked-about topics in wellness right now: GLP-1s. A naturopathic physician, podcast host, and expert in regenerative medicine, Dr. Moore has been at the forefront of the metabolic health conversation for years, and she's not afraid to challenge the hype.In their chat, Elizabeth and Dr. Moore get into what GLP-1s actually do in the body beyond weight loss, from regulating blood sugar to calming inflammation and supporting brain health. They unpack the potential of microdosing peptides as a tool, not a quick fix, and talk through the lifestyle habits that make or break your results. They also explore the limitations and risks of using GLP-1s without context, and the role of strength training, sleep, and upping your protein intake in hormone health. Episodes Here Say Hi To Elizabeth and Purely Elizabeth: Website | InstagramDr. Tyna Moore: Website | The Doctor Tyna Show

Resources for the Community___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials United States Patent & Trademark Office Website and Email https://www.uspto.gov/usptoinfo@uspto.govi-MAK Websitehttps://www.i-mak.org/i-MAK Briefs & Reports https://www.i-mak.org/resource-type/briefs/______________________________________________________________________Tahir Amin, founder of I-MAK, joins us to break down why GLP-1 meds like Ozempic and Mounjaro stay so pricey. We dig into evergreening, patent thickets, and how pharma companies use legal loopholes to delay generics and extend monopolies.We also explore why some companies spend more on stock buybacks than drug innovation—and what that means for access. If you've felt exploited by the system, you're not alone. But there's hope. Learn about the policy changes ahead and how you can take action to fight for affordable meds.Tahir Amin bio:Tahir Amin is a founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK), a nonprofit organisation working to address the systemic inequities in how medicines are developed and distributed. He has over 30 years of experience in intellectual property (IP) law, during which he has practised with two of the leading IP law firms in the United Kingdom and served as IP Counsel for multinational corporations. His work focuses on changing the structural power dynamics that allow health and economic inequities to persist by challenging and re-shaping IP laws and the related global political economy to better serve the public interest.  He is a former Harvard Medical School Fellow in the Department of Global Health & Social Medicine and has served as legal advisor/consultant to many international groups, including the European Patent Office and World Health Organization, as well as testifying before the U.S. Congress on intellectual property and unsustainable drug prices.Special Guest Co-Host, Amanda Bonello from GLP-1 Collective https://glp1collective.org/ _______________________________Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

I am honored to reconnect with Dr. Tracy Gapin today. He is a board-certified urologist and men's health expert.  The current state of metabolic health in the United States and most Westernized countries has sparked a great interest in a GLP1 agonist, AKA Semaglutide Ozempic. I wanted to speak with a clinician who actively uses this medication. Dr. Gapin and I discuss what this drug class represents. (These are synthetic peptides.) We speak about Semaglutide, Ozempic, Wegovy, and oral Rybelsus. We get into current research, side effects, who should not take these medications, the mechanisms of action specific to the pancreas and beta cells, reductions, gastric emptying, and the upregulation of satiety. We discuss changes in the brain regarding leptin and how these drugs work. We also talk about weight loss resistance, and I answer questions from listeners.  From my perspective, it all comes back to basics. I believe that if we are to prescribe these medications, we must help our patients understand how lifestyle impacts weight-loss resistance and metabolic health. I loved that Dr. Tracy spent some time talking about the specific ways he works with his patients, even before prescribing medications. He also explains how important he feels this drug has been for his patients. I approached today's conversation with an open mind, and I hope you will do the same. IN THIS EPISODE YOU WILL LEARN: GLP1 agonists, and how they help Dr. Tracy motivate his patients to lose weight What are GLP1 agonists, and how do they work? Physical benefits of GLP1 agonists Who is Semaglutide not appropriate for? Common side-effects of GLP1 agonists How those who fail to implement lifestyle changes when they stop using Semaglutide may regain all the weight they lost Hydration while using Semaglutide Protein intake when taking Semaglutide How to follow the metrics that matter Factors that could hinder successful weight loss What Dr. Tracy does to ensure his patients do not regain the weight they lost after they stop using Semaglutide Listener questions: Why is a diabetic drug being used for non-diabetics? Does this drug target muscle versus fat in terms of weight loss? For how long do most patients take it? Are there unique characteristics in perimenopausal and menopausal women that must be accounted for differently? Bio: Dr. Tracy Gapin is a board-certified urologist and a world-renowned expert in men's health and performance, as well as the founder of the Gapin Institute, the global leader in High-Performance Health.  He has over 20 years of experience focused on men's health optimization, human performance, and longevity, providing executives & entrepreneurs a personalized path to fulfill their highest potential. He's been featured in Entrepreneur, Dave Asprey's Biohacking Conference, and as a TEDx speaker. Connect with Cynthia Thurlow Follow on⁠ Twitter⁠,⁠ Instagram⁠ &⁠ LinkedIn⁠ Check out Cynthia's⁠ website⁠ Connect with Tracy Gapin On his⁠ website⁠ ⁠Gapin Institute⁠

Ozempic is one of the most import new medications in a generation. The scientist who created it is a self-described "nerd," who grew up on a farm in Denmark and has no interest in the limelight. Lotte Knudsen started her career working on laundry detergent enzymes, but eventually joined a team at the Danish pharmaceutical company Novo Nordisk that was tasked with looking for new treatments for diabetes. She was convinced that a recently discovered human hormone called GLP-1 could be made into a powerful medication, not only for Type 2 diabetes, but also for weight loss. It took 20 years of hard work and persistence for her and her team to figure it out, but their creation now shows promise as a worthy foe of heart disease, kidney disease, Parkinson's, alcoholism & Alzheimer's as well. In this episode Lotte Knudsen tells her story, and we hear from two of the other scientists who made critical contributions to this revolution in medicine: Mads Thomsen and Daniel Drucker.